Congratulations to Dr Jake Albrecht of BMS: Winner of AIChE QbD for Drug Substance Award, 2017

At AIChE Annual Meetings, Monday night is Awards night for the Pharma community, represented by PD2M.  This year in Minneapolis the award for Excellence in QbD for Drug Substance process development and scale-up went to Dr Jake Albrecht of Bristol-Myers Squibb.  Congratulations, Jake!

Winners are selected using a blinded judging panel selected by the Awards Chair, currently Bob Yule of GSK.  Awards criteria are:

• Requires contributions to the state of the art in the public domain (e.g. presentations, articles, publications, best practices)
• Winner may be in Industry, Academia, Regulatory or other relevant working environment
• Winner may be from any nation, working at any location
• There are no age or experience limits
• Preference is given to work that features chemical engineering

Jake was nominated by colleagues for:

• his innovative application of modeling methodologies and statistics to enable quality by design process development
• including one of the most downloaded papers in Computers and Chemical Engineering (2012-2013), “Estimating reaction model parameter uncertainty with Markov Chain Monte Carlo”
• his leadership and exemplary efforts to promote increasing adoption of modeling and statistical approaches by scientists within BMS and without
• his leadership in AIChE/PD2M through presentations, chairing meeting sessions, leading annual meeting programming and serving on the PD2M Steering Team

Scale-up Systems was delighted to be involved at the AIChE Annual Meeting this year in our continued sponsorship of this prize.  Some photos and video from the night made it onto our facebook page and more should appear soon on the PD2M website.

Jake is also a DynoChem power user and delivered a guest webinar in 2013 on connecting DynoChem to other programs, such as MatLab.